Cyclerion Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q2 2024 | 1 | $1.54 | $1.54 | $1.54 |
Cyclerion Therapeutics, Inc. Earnings Date And Information
Cyclerion Therapeutics, Inc. last posted its earnings results on Thursday, November 3rd, 2022. The company reported $-4.8 earnings per share for the quarter, topping analysts' consensus estimates of $-7 by $2.2. The company had revenue of 194,000 for the quarter and had revenue of 0 for the year. Cyclerion Therapeutics, Inc. has generated $-9 earnings per share over the last year ($-8.99 diluted earnings per share) and currently has a price-to-earnings ratio of -0.79. Cyclerion Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based on prior year's report dates.
Cyclerion Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.29 | $194,000 | $194,000 | ||
| 08/07/2024 | Q2 2024 | -$0.53 | $0 | $0 | ||
| 05/07/2024 | Q1 2024 | -$0.62 | $0 | |||
| 03/05/2024 | Q4 2023 | -$0.68 | $0 | |||
| 11/13/2023 | Q3 2023 | -$3.36 | $0 | |||
| 07/28/2023 | Q2 2023 | -$1.83 | $0 | |||
| 05/11/2023 | Q1 2023 | -$3.11 | $0 | |||
| 03/22/2023 | Q4 2022 | -$3.23 | $1.63 M | |||
| 11/03/2022 | Q3 2022 | -$7.00 | -$0.24 | 6.76 | $153,000 | $0 |
| 08/09/2022 | Q2 2022 | -$6.80 | -$0.31 | 6.49 | $355,500 | $72,000 |
| 05/04/2022 | Q1 2022 | -$7.20 | -$0.30 | 6.9 | $225,000 | |
| 02/24/2022 | Q4 2021 | -$6.40 | -$0.25 | 6.15 | $182,000 | |
| 11/09/2021 | Q3 2021 | -$5.80 | -$5.22 | 0.58 | $1.50 M | $77,000 |
| 07/29/2021 | Q2 2021 | -$9.06 | $3.00 M | |||
| 04/30/2021 | Q1 2021 | -$7.86 | $62,000 | |||
| 02/25/2021 | Q4 2020 | -$0.19 | -$0.60 | -0.41 | $133,000 | |
| 11/05/2020 | Q3 2020 | -$0.56 | -$11.72 | -11.16 | $400,000 | |
| 07/31/2020 | Q2 2020 | -$0.86 | -$14.06 | -13.2 | $749,000 | |
| 05/04/2020 | Q1 2020 | -$0.87 | -$14.62 | -13.75 | $1.01 M | |
| 03/12/2020 | Q4 2019 | -$0.89 | -$0.94 | -0.05 | $1.48 M |
Cyclerion Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Cyclerion Therapeutics, Inc.'s earnings date?
Cyclerion Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based off last year's report dates.
-
Did Cyclerion Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Cyclerion Therapeutics, Inc. (:CYCN) reported $-4.8 earnings per share (EPS) to beat the analysts' consensus estimate of $-7 by $2.2.
-
How can I listen to Cyclerion Therapeutics, Inc.'s earnings conference call?
The conference call for Cyclerion Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Cyclerion Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Cyclerion Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Cyclerion Therapeutics, Inc. generate each year?
Cyclerion Therapeutics, Inc. (:CYCN) has a recorded net income of $0. Cyclerion Therapeutics, Inc. has generated $-8.99 earnings per share over the last four quarters.
-
What is Cyclerion Therapeutics, Inc.'s price-to-earnings ratio?
Cyclerion Therapeutics, Inc. (:CYCN) has a price-to-earnings ratio of -0.79 and price/earnings-to-growth ratio is -0.01.
